In today's increasingly strict compliance requirements for excipients in the pharmaceutical industry, a pharmaceutical company in Guangdong has accurately selected Nanjing Chemical Reagent's subsidiaryNantest brand potassium acetate pharmaceutical excipientInject compliance and quality assurance into its production process. It is worth mentioning that the medicinal excipient of potassium acetate in the southern trial has successfully passed the CDE public announcement, with registration numberF20240000044 and F20240000045This certification has become the core trust bond for both parties' cooperation.


Potassium acetate: the "invisible guardian" of pharmaceutical excipients, playing multiple key roles in drug formulations:
1. pH regulator: Potassium acetate can accurately adjust the pH value of sterile preparations such as injections and infusions, ensuring drug stability and bioavailability;
2. Electrolyte supplements: In the field of clinical nutritional support, potassium acetate is the core component of compound electrolyte injection, used to correct hypokalemia and maintain fluid balance;
3. Sustained release excipients: In oral solid formulations, potassium acetate can improve patient medication adherence by regulating drug release rate.

Nanjing reagentproductionPotassium acetate pharmaceutical excipientBy using high-purity raw materials and fully automated production processes, key indicators such as heavy metals, microbial limits, and residual solvents are strictly controlled, in compliance with the 2025 edition of the Chinese Pharmacopoeia and international mainstream pharmacopoeia standards. Its product has uniform particle size and excellent solubility, which can meet the process requirements of different dosage forms and provide a solid guarantee for the stability and consistency of the formulation. The two companies will take this cooperation as an opportunity to further strengthen cooperation in areas such as technological innovation, product research and development, and market expansion, and jointly promote the high-quality development of China's pharmaceutical industry.